Ion Exchange India Ltd (IONEXCHANG) Q3FY26 Concall Summary - Dec-2025 Qtr
Performance Overview
- The company reported a modest 6% year-on-year revenue growth, but profitability was significantly impacted, with EBITDA declining by 21% and net profit also showing a decline.
- The Engineering division's performance was flat year-on-year, primarily due to the deferral of high-value international project dispatches to Q4 and muted execution of the UP Jal Jeevan Mission (JJM) order.
- The Chemicals division saw a 16% revenue increase, but its profitability moderated due to an adverse product mix and the initial impact of the new Roha facility's depreciation and interest costs.
- The Consumer Products division continued its strong growth trajectory with a 28% year-on-year revenue increase, driven by healthy volumes, though the company continues to invest heavily in branding and marketing, resulting in a small loss.
- Management highlighted a strong order inflow, which has already surpassed the total intake of the previous financial year in the first nine months, indicating a healthy future pipeline despite being more selective in project acquisition.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.